Skip to main content

Acrisure Capital Management, LLC

SEC CIK
0001913905
Latest filing
Jul 12, 2023

The latest 13F from Acrisure Capital Management, LLC covers Q2 2023 (filed Jul 12, 2023) and reports no long positions. Livermore has 3 filings on Form 13F from this institution, going back to Q4 2022.

What changed in Q2 2023

Share counts compared with Q1 2023: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.

Full comparison
New
0
Added
0
Reduced
0
Sold out
251
Est. −$98.8M

Top 5 holdings

Share of this quarter's portfolio value

This filing reports no long positions.

Biggest buys

New and added positions, by estimated amount bought

None this quarter.

Largest weight increases

New and added positions, by percentage points of the portfolio gained

None this quarter.

Biggest sells

Reduced and sold-out positions, by estimated amount sold

  1. AEPAmerican Electric Power Co Inc
    −$2.30MSold outHistory
  2. OGEOGE Energy Corp.
    −$1.57MSold outHistory
  3. METMetlife Inc
    −$1.42MSold outHistory
  4. MAMastercard Inc
    −$1.27MSold outHistory
  5. MRSHMarsh & McLennan Companies, Inc.
    −$1.18MSold outHistory

Largest weight decreases

Reduced and sold-out positions, by percentage points of the portfolio lost

  1. AEPAmerican Electric Power Co Inc
    −2.33 pp2.3% → 0.0%History
  2. OGEOGE Energy Corp.
    −1.59 pp1.6% → 0.0%History
  3. METMetlife Inc
    −1.44 pp1.4% → 0.0%History
  4. MAMastercard Inc
    −1.29 pp1.3% → 0.0%History
  5. MRSHMarsh & McLennan Companies, Inc.
    −1.19 pp1.2% → 0.0%History

Metrics

13F metrics for Q2 2023, computed only from the numbers in the filings. Definitions below.

Portfolio value
$0
−$98.8M (−100.0%) vs. prior quarter
Positions
0
−251 vs. prior quarter
Top 10 concentration
–
Top 10 as share of value
Turnover
0.0%
Q2 2023, one quarter
Average holding period
–
Weighted by value

How these are calculated

  • Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
  • Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
  • Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
  • Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q4 2022), so positions held before then are understated.

13F filings by quarter

3 quarters, going back to Q4 2022. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.

Peak $98.8M (Q1 2023)

Q4 2022: $90.3MQ1 2023: $98.8M
Q4 2022Q2 2023
13F filings of Acrisure Capital Management, LLC by quarter
QuarterFiledPositionsValueTop 3 holdingsChangesFiling
Q2 2023Jul 12, 20230$0–vs. Q1 2023SEC
Q1 2023May 15, 2023251$98.8MAEPOGEMETvs. Q4 2022SEC
Q4 2022Mar 28, 2023254$90.3MJNJMRSHPEP–SEC